Is It Too Late to Buy Pfizer Stock? [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
like its recent stint of unprofitability and a beaten-down top line being the primary pieces of supporting evidence. But even the best companies can sometimes have a few quarters of difficulty, and investors should hesitate before counting this stock out. Let's analyze the arguments on each side and reach an actionable conclusion. The argument for it being too late What does it even mean for someone to say that it's too late to buy shares of one of the world's biggest and best-known pharmaceutical stocks? Perhaps Pfizer's detractors believe that the majority of the growth opportunity is in the past. One quick look at this chart indicates that they might be on to something: As you can see, its trailing-12-month revenue and earnings are currently trending downward, with either anemic growth or a decline over the last 10 years. And its net losses over that period total $309 million, which also suggests that its dividend could be at risk of a cut. When paired with the company's
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Sarepta's Elevidys secures US label expansion for DMD [Yahoo! Finance]Yahoo! Finance
- Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug [Yahoo! Finance Canada]Yahoo! Finance Canada
- Dyspareunia Treatment Market to Hit $1,035.4 million by 2031, at a CAGR of 4.6%, says Coherent Market Insights [Yahoo! Finance]Yahoo! Finance
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi's Executive Committee [Yahoo! Finance]Yahoo! Finance
- Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/11/24 - Form 11-K
- PFE's page on the SEC website